Portfolio company
CareDx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops molecular transplant monitoring tests and workflow software for transplant centres, clinicians and patients to manage organ health and rejection risks.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Warehouse
This company develops smartphone-enabled biosensor devices that allow transplant and dialysis patients to monitor drug levels and biomarkers from home for clinical review.
Optim'Care
This company develops digital monitoring software for transplant patients to improve medical follow-up and clinical outcomes for healthcare providers.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
CareX AI
This company develops AI software that converts camera-equipped devices into medical tools for monitoring patient vital signs in hospitals and remote care settings.
Adaptive Biotechnologies
This company provides immune-sequencing tests and research services for clinicians, biopharmaceutical firms and academic researchers to diagnose, monitor and treat diseases.
Guardant Health
The company develops blood-based tests to detect and monitor cancer for patients, healthcare providers, and biopharmaceutical researchers.
CVRx
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
Nimble Dx
This company develops a non-invasive medical device for clinicians to monitor and diagnose complications in patients with implanted cardiovascular stents.
